Kubota Pharmaceutical Holdings Co., Ltd. (TYO:4596)
51.00
0.00 (0.00%)
Aug 29, 2025, 3:30 PM JST
TYO:4596 Revenue
Kubota Pharmaceutical Holdings had revenue of 4.76M JPY in the quarter ending June 30, 2025, with 18.88% growth. This brings the company's revenue in the last twelve months to 30.00M, down -3.23% year-over-year. In the year 2024, Kubota Pharmaceutical Holdings had annual revenue of 27.00M, down -30.77%.
Revenue (ttm)
30.00M
Revenue Growth
-3.23%
P/S Ratio
104.11
Revenue / Employee
1.58M
Employees
19
Market Cap
3.12B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 27.00M | -12.00M | -30.77% |
Dec 31, 2023 | 39.00M | 31.00M | 387.50% |
Dec 31, 2022 | 8.00M | - | - |
Dec 31, 2021 | - | - | - |
Dec 31, 2020 | 37.00M | - | - |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Chugai Pharmaceutical | 1,196.21B |
Takeda Pharmaceutical Company | 4,480.25B |
Daiichi Sankyo Company | 1,924.68B |
HOYA Corporation | 876.09B |
Otsuka Holdings | 2,401.70B |
Terumo | 1,037.94B |
Astellas Pharma | 1,944.99B |
Shionogi & | 440.50B |